In 2019, Frier Levitt reported a new dispensing limitation CVS Caremark (“Caremark”) introduced in its retail networks that took effect on January 1, 2020. Specifically, Caremark issued an “Aberrant Product List” that identified... Read More
Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences

On June 9, 2020 the U.S. Department Health and Human Services (“DHHS”) announced that it was allocating a total of $15 Billion in Provider Relief Fund payments to Medicaid or Children’s Health Insurance Program (CHIP) providers who have been... Read More
Blogs & Articles | COVID-19 Resources | Healthcare Law | Medicare and Insurance Audits

If there were ever any doubts about the seriousness of CMS’ commitment to transitioning the nation’s healthcare system from one based on volume-based to value-based compensation models, those doubts were squashed by a recent CMS blog post and... Read More
COVID-19 Resources | Healthcare Law | Pharmacy Law | Value Based Care

As part of our firm’s commitment to staying abreast of COVID19-related issues affecting our clients, we are continuing to monitor financial relief program requirements and other important topics.  While applying for various forms of aid and... Read More
Ambulatory Care Facility Formation & Representation | Blogs & Articles | COVID-19 Resources | Dental Practices | Employment Matters | Healthcare | Healthcare Law | Medical Spas and Cosmetic Services

COVID-19 is having a profound effect on clinical trials for medical products, including drugs, devices and biological products. Site closures, travel restrictions, quarantines, infections among participants and trial personnel, and investigational... Read More
Blogs & Articles | COVID-19 Resources | Healthcare | Healthcare Law | Laboratories | Regulatory Compliance, including FDA, DEA and HIPAA